The use of genomic testing in infection control could save 650 lives a year in Qld
Genomic sequencing technology helps to track, treat and prevent hospital acquired infections. It’s also overhauling the way we respond to and prevent outbreaks.
Whole genome sequencing has the biggest impact where current practice does not provide enough information to prevent the spread of infection.
This Toolkit is for anyone working in infectious diseases – from those involved in day-to-day infection control practices in hospitals and health facilities – to the scientists working behind the scenes in the lab identifying organisms and interpreting data.
A collective knowledge of all specialties will enhance all aspects of bacterial genomics application in health, from sample collection, bioinformatics analysis, and microbiology reporting, through to hospital-based infectious diseases and infection prevention and control responses.
This Toolkit provides a starting point for clinicians and scientists working in bacterial genomics to understand the knowledge base for each specialty. Those armed with knowledge and an understanding beyond their own specialty area, will be best placed to actively participate in multidisciplinary team discussions and ultimately enhance care.
How do infections spread and what can we do to minimise the risk and spread of infection?
Learn about what an infection control nurse does and key areas of responsibility.
Your introduction to the microbial world, including what a typical lab workflow looks like.
An overview of what genomics is from a bioinformatics perspective.
Find out how genomics can improve infection control. Case study included.
Queensland Genomics hosted a Microbial & Infection Control Genomics Workshop in November 2019. The workshop demonstrated the potential of microbial genomics and how to apply it to hospital outbreaks and infection control management. Access recordings of the workshop sessions here.
Queensland Genomics partnered with QIMR Berghofer to develop resources to support Aboriginal & Torres Strait Islander peoples in accessing genomics and personalised medicine.